anxiety with semaglutide reduces risk of worsening and depression | Professor Erwin Loh posted on the topic GLP-1 diabetes drugs could stop

All statistical analyses and graph plotting were carried out using GraphPad Prism software version 9 (GraphPad Software, Inc., La Jolla, CA, United States)

While previous studies highlighted some of these risks in patients with diabetes, this is the first large, population-level study to examine adverse gastrointestinal events in non-diabetic patients using the drugs specifically for weight loss

However, the risk increases if its taken with insulin or sulfonylureas, so dose adjustments may be needed

Good sleep habits

10.7759/cureus.9319 75 MarusichJ

It was reported that aldose reductase inhibitors, such as epalrestat, reduced ROS levels and retinal lipid peroxidation in diabetic rats, suggesting a therapeutic avenue (54)